Postpartum Anemia Clinical Trial
Official title:
A Comparison Between Two Strategies for Postpartum Anemia Diagnosis and Follow up After Vaginal Deliveries - Hemoglobin Screening in High Risk Population Versus by Symptoms
Verified date | May 2017 |
Source | HaEmek Medical Center, Israel |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Anemia diagnosis by hemoglobin level monitoring in women after vaginal delivery by symptoms versus screening of women at increased risk for post-partum anemia.
Status | Completed |
Enrollment | 1679 |
Est. completion date | May 2017 |
Est. primary completion date | May 2017 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - pregnant women after vaginal delivery Exclusion Criteria: - pregnant women with known sensitivity to the product iron sucrose - pregnant women after cesarean section |
Country | Name | City | State |
---|---|---|---|
Israel | Haemek Medical Center | Afula |
Lead Sponsor | Collaborator |
---|---|
HaEmek Medical Center, Israel |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The rate of patients diagnosed with anemia | Hemoglobin of 10 g/dl or below | Up to 3 days postpartum | |
Primary | The rate of patients who received treatment with intravenous iron sucrose | Up to 3 days postpartum | ||
Secondary | The rate of patients who received blood transfusion | From delivery and up to 5 days | ||
Secondary | The rate of women with post-partum hemorrhage | From delivery and up to 5 days | ||
Secondary | The rate of women who underwent uterine revision following delivery after their arrival to the maternity ward | From delivery and up to 5 days | ||
Secondary | The rate of women who needed uterotonic agents after their arrival to the maternity ward | From delivery and up to 5 days | ||
Secondary | The average blood tests number that was performed | From delivery and up to 5 days | ||
Secondary | Minimal and average hemoglobin level | From delivery and up to 5 days | ||
Secondary | The composite symptoms of anemia and functional capacity after 6 weeks postpartum as assessed by a questionnaire | Each question in the questionnaire will receive a score. The total score will be reported. | 6 weeks postpartum | |
Secondary | Hemoglobin level 6 weeks postpartum | 6 weeks postpartum |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05590260 -
Prevention of Iron Deficiency Anemia Post-delivery
|
Phase 3 | |
Completed |
NCT01628770 -
Use of Iron Isomaltoside 1000 (Monofer) in Postpartum Anemia
|
N/A | |
Completed |
NCT00354484 -
Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients
|
Phase 3 | |
Recruiting |
NCT02656225 -
Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06175117 -
Clinical Study on the Treatment of Postpartum Anemia With Compound E Jiao Jiang(cEJJ)
|
Phase 4 | |
Completed |
NCT02458625 -
A Comparison Between Intravenous Iron Sucrose to Its Combination With Oral Iron Supplements for the Treatment of Postpartum Anemia
|
N/A |